MSSMY yields 1.74% · PFE yields 6.13%● Live data
📍 MSSMY pulled ahead of the other in Year 1
Combined, MSSMY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MSSMY + PFE for your $10,000?
MISUMI Group Inc. engages in the factory automation and die components businesses worldwide. The company operates through three segments: FA Business, Die Components Business, and VONA Business. It offers mechanical components, including shafts, timing pulleys, linear bushings, and flat belt conveyors; and locator devices and measurement equipment, such as automatic stage units, actuators, optical measurement devices, and optical waveguide alignment products. The company also provides s metal press/plastic mold components comprising punches, button dies, guide pins, gas springs, ejector pins, sprue bushings, parting lock sets, and taper pins. In addition, it distributes sensors and switches, couplings, screws, bolts, nuts, castors, connectors, switches, cables, transformers, end mills, hexagonal wrenches, milling chips, calipers, carts, work gloves, parts cleaners, and laboratory equipment and supplies. MISUMI Group Inc. was incorporated in 1963 and is headquartered in Tokyo, Japan.
Full MSSMY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.